Emerging from the Shadow of Hemagglutinin: Neuraminidase Is an Important Target for Influenza Vaccination
- 1 December 2019
- journal article
- editorial
- Published by Elsevier in Cell Host & Microbe
- Vol. 26 (6) , 712-713
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Allergy and Infectious Diseases
This publication has 11 references indexed in Scilit:
- Influenza H7N9 Virus Neuraminidase-Specific Human Monoclonal Antibodies Inhibit Viral Egress and Protect from Lethal Influenza Infection in MiceCell Host & Microbe, 2019
- Structural Basis of Protection against H7N9 Influenza Virus by Human Anti-N9 Neuraminidase AntibodiesCell Host & Microbe, 2019
- Broadly protective human antibodies that target the active site of influenza virus neuraminidaseScience, 2019
- The human antibody response to influenza A virus infection and vaccinationNature Reviews Immunology, 2019
- NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines?mBio, 2018
- Influenza Infection in Humans Induces Broadly Cross-Reactive and Protective Neuraminidase-Reactive AntibodiesCell, 2018
- Influenza neuraminidaseInfluenza and Other Respiratory Viruses, 2011
- Inhibition of Influenza Virus Replication in Tissue Culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): Mechanism of ActionJournal of General Virology, 1976
- EFFECT OF NEURAMINIDASE ANTIBODY ON HONG KONG INFLUENZAThe Lancet, 1973
- Association of Serum Anti-Neuraminidase Antibody with Resistance to Influenza in ManNew England Journal of Medicine, 1972